TransMedics Group

Update in progress

TMDX (NasdaqGM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

TransMedics Group, Inc. is a commercial-stage medical technology company transforming organ transplant therapy. It offers the Organ Care System (OCS), a portable perfusion and monitoring platform that recreates near-physiologic conditions for donor organs outside the body. OCS LUNG, OCS Heart and OCS Liver preserve lungs, hearts and livers. The company also provides a national OCS program and logistics services, founded in 1998 and based in Andover, MA.

Company score

Sentiment: 0.15; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.08; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.31; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.04; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.06; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive